Dr Dilip Kumar, Interventional Cardiologist, Medica Superspecialty Hospital, Kolkata, West Bengal, India points out that in stent technology, the platform, drug and delivery system, all are important. The way forward is to improve all these components. He also emphasises that a lot of good Indian companies are coming up with good stents as clearly shown by the TALENT trial which demonstrated that Supraflex Cruz stent was at par with the Xience stent, which is considered the gold standard
To view other videos in this series of Indian Stents: Get Updated – Season 2, please click on the banner below:
| Previous | Next |
| Dr P Mangalanandan |
Dr Arun K Chopra |